SCHEMBL5151206

SCHEMBL5151206

O=C(O)CCn1c2ccccc2c2ccc(OCCCCOc3ccc([N+](=O)[O-])cc3)cc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.53
FABP5 Q01469 3/20 0.53
FABP3 P05413 1/20 0.53
PSEN1 P49768 7/20 0.53
PSEN2 P49810 7/20 0.53
APH1B Q8WW43 7/20 0.53
NCSTN Q92542 7/20 0.53
APH1A Q96BI3 7/20 0.53
PSENEN Q9NZ42 7/20 0.53
MAPT P10636 2/20 0.49
POLB P06746 1/20 0.49
ATM Q13315 1/20 0.49
PKM P14618 2/20 0.48
DRD2 P14416 1/20 0.46
DRD4 P21917 1/20 0.46
DRD3 P35462 1/20 0.46
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
HTR5A P47898 1/20 0.45
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5152498 0.90 KDM4E (0.50) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5151535 0.90 FABP4 (0.62) FABP4FABP5FABP3PSEN1PSEN2
SCHEMBL5154848 0.89 PSEN1 (0.50) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5154961 0.88 PSEN1 (0.49) FABP4FABP5FABP3PSEN1PSEN2
SCHEMBL5149618 0.86 FABP4 (0.57) FABP4FABP5FABP3PSEN1PSEN2
SCHEMBL5154856 0.86 PSEN1 (0.58) FABP4FABP5FABP3PSEN1PSEN2
SCHEMBL5154811 0.86 PSEN1 (0.58) FABP4FABP5FABP3PSEN1PSEN2
SCHEMBL5149567 0.86 FABP4 (0.57) FABP4FABP5FABP3PSEN1PSEN2
SCHEMBL5151312 0.84 FABP4 (0.58) FABP4FABP5FABP3PSEN1PSEN2
SCHEMBL5152637 0.84 FABP4 (0.52) FABP4FABP5FABP3PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US claimed
WO-2007071456-A1 FLUORENES AND CARBAZOLES AS LIGANDS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 WO claimed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197524-A1 Fluorenes and carbazoles as ligands of the EP2 receptor PTGER2, PTGER1, PTGDR2 FABP4 1591/4885FABP5 901/4885FABP3 535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.